These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31519377)

  • 1. Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.
    Suematsu Y; Kawachi E; Idemoto Y; Matsuo Y; Kuwano T; Kitajima K; Imaizumi S; Kawamura A; Saku K; Uehara Y; Miura SI
    Int J Cardiol; 2019 Dec; 297():111-117. PubMed ID: 31519377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.
    Uehara Y; Ando S; Yahiro E; Oniki K; Ayaori M; Abe S; Kawachi E; Zhang B; Shioi S; Tanigawa H; Imaizumi S; Miura S; Saku K
    J Am Heart Assoc; 2013 May; 2(3):e000048. PubMed ID: 23709562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo.
    Shimizu T; Tanigawa H; Miura S; Kuwano T; Takata K; Suematsu Y; Imaizumi S; Yahiro E; Zhang B; Uehara Y; Saku K
    Int J Cardiol; 2015 Aug; 192():82-8. PubMed ID: 26005953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
    Ikenaga M; Higaki Y; Saku K; Uehara Y
    J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
    Xie Q; Zhao SP; Li F
    Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway.
    Takata K; Imaizumi S; Kawachi E; Yahiro E; Suematsu Y; Shimizu T; Abe S; Matsuo Y; Nakajima K; Yasuno T; Jimi S; Zhang B; Uehara Y; Miura S; Saku K
    Int J Cardiol; 2016 Mar; 207():317-25. PubMed ID: 26814636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCA1 (ATP-Binding Cassette Transporter A1) Mediates ApoA-I (Apolipoprotein A-I) and ApoA-I Mimetic Peptide Mobilization of Extracellular Cholesterol Microdomains Deposited by Macrophages.
    Jin X; Sviridov D; Liu Y; Vaisman B; Addadi L; Remaley AT; Kruth HS
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2283-2291. PubMed ID: 27758769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE
    Gou S; Wang L; Zhong C; Chen X; Ouyang X; Li B; Bao G; Liu H; Zhang Y; Ni J
    Br J Pharmacol; 2020 Oct; 177(20):4627-4644. PubMed ID: 32726461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.
    Iizuka M; Ayaori M; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Sasaki M; Komatsu T; Yogo M; Kishimoto Y; Kondo K; Ikewaki K
    J Nutr Sci Vitaminol (Tokyo); 2012; 58(2):96-104. PubMed ID: 22790567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
    Hafiane A; Bielicki JK; Johansson JO; Genest J
    PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway.
    Suematsu Y; Miura S; Takata K; Shimizu T; Kuwano T; Imaizumi S; Matsuo Y; Yahiro E; Uehara Y; Saku K
    Int J Cardiol; 2016 Jan; 202():810-6. PubMed ID: 26476037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel molecular imaging of atherosclerosis with gallium-68-labeled apolipoprotein A-I mimetic peptide and positron emission tomography.
    Kawachi E; Uehara Y; Hasegawa K; Yahiro E; Ando S; Wada Y; Yano T; Nishikawa H; Shiomi M; Miura S; Watanabe Y; Saku K
    Circ J; 2013; 77(6):1482-9. PubMed ID: 23459406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.
    Ditiatkovski M; Palsson J; Chin-Dusting J; Remaley AT; Sviridov D
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1301-1306. PubMed ID: 28522696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.